Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Cleveland Clinic · West Los Angeles College
Abstract
Multiple sclerosis is an inflammatory disease of the central nervous system that destroys myelin, oligodendrocytes, and axons. Since most of the lesions of multiple sclerosis are not remyelinated, enhancement of remyelination is a possible therapeutic strategy that could perhaps be achieved with the transplantation of oligodendrocyte-producing cells into the lesions. We investigated the frequency distribution and configuration of oligodendrocytes in chronic lesions of multiple sclerosis to determine whether these factors limit remyelination.
Forty-eight chronic lesions obtained at autopsy from 10 patients with multiple sclerosis were examined immunocytochemically for oligodendrocytes and oligodendrocyte progenitor cells. Using confocal microscopy, we examined the three-dimensional relations between axons and the processes of premyelinating oligodendrocytes.
Citation impact
- FWCI
- 12.66
- Percentile
- 100%
- References
- 39
Authors
4Topics & keywords
- Remyelination
- Multiple sclerosis
- Oligodendrocyte
- Myelin
- Medicine
- Pathology
- Demyelinating disease
- Central nervous system
- Good health and well-being